GLD 40 Pill: brown, capsule/oblong
The pill with imprint GLD 40 (Brown, Capsule/Oblong, 0mm) has been identified as Doxycycline (Anhydrous) Immediate/Delayed Release 40 mg (immediate release 30 mg / delayed release 10 mg) and is used for Actinomycosis, Acne, Amebiasis, Anthrax, and Gonococcal Infection, Uncomplicated. It belongs to the drug classes miscellaneous antimalarials, tetracyclines and is not a controlled substance.
Images for GLD 40
Doxycycline (Anhydrous) Immediate/Delayed Release
- Imprint
- GLD 40
- Strength
- 40 mg (immediate release 30 mg / delayed release 10 mg)
- Color
- Brown
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous antimalarials, Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Owen Laboratories, Inc.
- Inactive Ingredients
-
hypromelloses,
ferric oxide red,
ferric oxide yellow,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
polyethylene glycol,
polysorbate 80,
sucrose,
magnesium silicate,
titanium dioxide,
triethyl citrate
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00299-3822 | Galderma Laboratories, L.P. |
66993-0815 (Discontinued) | Prasco Laboratories |
69007-0822 (Discontinued) | |
54868-5676 (Discontinued) | Physicians Total Care Inc. (repackager) |
Related images for "GLD 40"
More about doxycycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,642)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: miscellaneous antimalarials
- Breastfeeding
- En español
Patient resources
Other brands
Vibramycin, Monodox, Doryx, Doryx MPC, ... +8 more
Professional resources
- Doxycycline monograph
- Doxycycline (Topical) (AHFS Monograph)
- Doxycycline Hyclate (EENT) (AHFS Monograph)
- Doxycycline (FDA)
- Doxycycline Delayed Release Capsule (FDA)
Other brands
Vibramycin, Monodox, Doryx, Oracea, ... +7 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.